Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$644,746
+$16,333 QoQ
Shares Held
4,114
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#780
of 1,606 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THORNBURG INVESTMENT MANAGEMENT INC holds $1,317,069,132 across 7 Drug Manufacturers - General names. NVS ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,891,426 | $548,272,198 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,787,976 | $486,754,916 | |
| 3 | ABBV |
AbbVie Inc.
|
541,146 | $136,173,979 | |
| 4 | LLY |
ELI LILLY & Co
|
79,682 | $95,572,989 | |
| 5 | PFE |
Pfizer Inc
|
1,970,004 | $47,437,696 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
38,400 | $2,212,608 | |
| 7 | NVS |
Novartis AG
This page
|
4,114 | $644,746 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $644,746 | 4,114 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $628,413 | 4,114 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $674,046 | 4,889 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $626,965 | 4,889 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $591,617 | 4,889 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $545,025 | 4,889 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $759,018 | 7,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $897,156 | 7,800 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $830,388 | 7,800 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $754,494 | 7,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $690,028 | 6,834 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $754,986 | 7,412 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $747,944 | 7,412 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $681,904 | 7,412 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $559,923 | 6,172 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $469,133 | 6,172 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $521,719 | 6,172 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $589,855 | 6,722 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $926,744 | 10,595 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $766,278 | 9,370 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $854,918 | 9,370 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $800,947 | 9,370 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $884,809 | 9,370 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $814,815 | 9,370 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $818,375 | 9,370 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $772,556 | 9,370 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||